Browsing by Author Whiting, Malcolm

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2011Associations between the use of metformin, sulphonylureas, or diet alone and cardiovascular outcomes in 6005 patients with type 2 diabetes in the FIELD studyDonoghoe, Mark; Forder, Peta; Keech, Anthony (Tony); Kritharides, Leonard; Merrifield, Alistair; Simes, Robert John; Sullivan, David; Colman, P. G.; Haapamäki, Hannu; Neil, Graham; Whiting, Malcolm; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Concord Clinical School: ANZAC Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Molecular BioscienceAssociations between the use of metformin, sulphonylureas, or diet alone and cardiovascular outcomes in 6005 patients with type 2 diabetes in the FIELD study, Diabetes Research and Clinical Practice, vol.94, 2, 2011,pp 284-290
2006Neither plasma coenzyme Q(10) concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case-control study from the LIPID study.Pollicino, Christine; Simes, Robert John; Stocker, Roland; Sullivan, David; Colquhoun, David; Gay, Craig A.; Nestel, Paul; Tonkin, Andrew; Whiting, Malcolm; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Medical Sciences: Pathology; School of Molecular BioscienceNeither plasma coenzyme Q(10) concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case-control study from the LIPID study., Atherosclerosis, vol.187,(1),2006,pp 198-204
2012Plasma homocysteine and the risk of venous thromboembolism: Insights from the FIELD studyKeech, Anthony (Tony); Veillard, Anne-Sophie; Ehnholm, Christian; Herrmann, Markus; Sullivan, David; Whiting, Malcolm; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentrePlasma homocysteine and the risk of venous thromboembolism: Insights from the FIELD study, Clinical Chemistry and Laboratory Medicine, vol.50, 12, 2012,pp 2213-2219
2013Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the fenofibrate intervention and event lowering in diabetes (field) studyChan, Kim; Donoghoe, Mark; Hoffmann, Linda Sarah; Keech, Anthony (Tony); Ng, Martin; O'Connell, Rachel; Rajamani, Kushwin; Stocker, Roland; Sullivan, David; Yu, Bing; Hamer, A; Vanhala, Mauno J; Whiting, Malcolm; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Medical Sciences: Bosch Institute; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Heart Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: Public Health; School of Medical Sciences: Pathology; Molecular Bioscience; Central Clinical School: MedicinePlasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the fenofibrate intervention and event lowering in diabetes (field) study, Diabetologia: clinical and experimental diabetes and metabolism, vol.56, 4, 2013,pp 724-736
2009Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with Type 2 diabetes treated with fenofibrateBarter, Philip; Keech, Anthony (Tony); Simes, Robert John; Sullivan, David; Zannino, Diana; Ehnholm, Christian; Taskinen, M.; Whiting, Malcolm; Central Clinical School: Heart Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreRelationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with Type 2 diabetes treated with fenofibrate, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.29, 6, 2009,pp 950-955
2005Science Programs for a 2-m Class Telescope at Dome C, Antarctica:PILOT, the Pathfinder for an International Large Optical TelescopeBedding, Timothy; Bland-Hawthorn, Jonathan; Lewis, Geraint; Tuthill, Peter; Ashley, M C B; Bailey, John A.; Blake, Chris; Bond, I A; Burton, M G; et, al; Glazebrook, Karl; Lawrence, J S; Whiting, Malcolm; Physics; Physics; Physics; PhysicsScience Programs for a 2-m Class Telescope at Dome C, Antarctica:PILOT, the Pathfinder for an International Large Optical Telescope, Publications of the Astronomical Society of Australia, vol.22,(3),2005,pp 199-235